Veraxa Biotech implements FDA-aligned testing methods

Veraxa Biotech has adopted FDA-aligned New Approach Methodologies, including cell-based assays and organ-on-chip systems, to reduce animal testing and improve clinical prediction in its cancer therapeutic development programs.

This Wire brief sits within Fusion42's coverage of Biotech, and 3 sources have reported it.